Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorSTRITT, Simon
dc.contributor.authorNURDEN, Paquita
dc.contributor.authorNURDEN, Alan T.
dc.contributor.authorSCHVED, Jean-Francois
dc.contributor.authorBORDET, Jean-Claude
dc.contributor.authorROUX, Maguelonne
dc.contributor.authorALESSI, Marie-Christine
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorTREGOUET, David-Alexandre
dc.contributor.authorMAKINEN, Taija
dc.contributor.authorGIANSILY-BLAIZOT, Muriel
dc.date.accessioned2022-06-09T10:48:28Z
dc.date.available2022-06-09T10:48:28Z
dc.date.issued2022-05-31
dc.identifier.issn1592-8721 (Electronic) 0390-6078 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/140166
dc.description.abstractEnVascular homeostasis is impaired in various diseases thereby contributing to the progression of their underlying pathologies. The endothelial immediate early gene Apolipoprotein L domain-containing 1 (APOLD1) helps regulate endothelial function. However, its precise role in endothelial cell (EC) biology remains unclear. We have immuno-localized APOLD1 to EC cell contacts and to Weibel- Palade bodies (WPB) where it associates with von Willebrand factor (VWF) tubules. Silencing of APOLD1 in primary human ECs disrupted the cell junction-cytoskeletal interface, thereby altering endothelial permeability accompanied by spontaneous release of WPB contents. This resulted in an increased presence of WPB cargoes, notably VWF and ANGPT2 in the extracellular medium. Autophagy flux, previously recognized as an essential mechanism for the regulated release of WPBs, was impaired in the absence of APOLD1. In addition, we report APOLD1 as a candidate gene for a novel inherited bleeding disorder (IBD) across three generations of a large family associating an atypical bleeding diathesis with episodic impaired microcirculation. A dominant heterozygous nonsense APOLD1:p.R49* variant segregated to affected family members. Compromised vascular integrity resulting from an excess of plasma ANGPT2, and locally impaired availability of VWF may explain the unusual clinical profile of APOLD1:p.R49* patients. In summary, our findings identify APOLD1 as an important regulator of vascular homeostasis and raise the need to consider testing of EC function in patients with IBDs without apparent platelet or coagulation defects.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.title.enAPOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis
dc.typeArticle de revueen_US
dc.identifier.doi10.3324/haematol.2022.280816en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35638551en_US
bordeaux.journalHaematologicaen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamELEANOR_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03691783
hal.version1
hal.date.transferred2022-06-09T10:48:34Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Haematologica&rft.date=2022-05-31&rft.eissn=1592-8721%20(Electronic)%200390-6078%20(Linking)&rft.issn=1592-8721%20(Electronic)%200390-6078%20(Linking)&rft.au=STRITT,%20Simon&NURDEN,%20Paquita&NURDEN,%20Alan%20T.&SCHVED,%20Jean-Francois&BORDET,%20Jean-Claude&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée